Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
about
Autoimmune liver serology: current diagnostic and clinical challengesRNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaeaAntibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitisAutoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the diseaseAutoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyUpdate on Autoimmune HepatitisSynthesis and decoding of selenocysteine and human healthStructure and catalytic mechanism of eukaryotic selenocysteine synthaseStructural insights into RNA-dependent eukaryal and archaeal selenocysteine formationDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsCorrelation of autoantibodies presence detected by IFA-anti-dsDNA, IFA-AMA and immunoblotting with corresponding data in clinical management of autoimmune diseases.Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology.Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.Understanding the pathogenesis of autoimmune hepatitis.Liver immunology.Review article: autoimmune hepatitis -- current management and challenges.Autoimmune hepatitis and its variant syndromes.Animal models of autoimmune liver disease.Mechanisms of liver injury relevant to pediatric hepatology.Hepatocellular carcinoma in patients with autoimmune hepatitis.Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance.Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.Autoimmune hepatitis. Making sense of all those antibodies.Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristicsAutoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitisAssociation between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.Autoimmune hepatitis and sclerosing cholangitis.Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentanAutoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.Serum autoantibodies: a road map for the clinical hepatologist.Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitisAutoimmune hepatitis. Part B: diagnosis.Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers.Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis.Cutting edge issues in autoimmune hepatitis.Advances in the current treatment of autoimmune hepatitis.
P2860
Q24644140-6827C089-8E68-4EBF-A376-DE201DAC0B42Q24678069-BF09E13B-DC31-49F8-98CF-DAC87BC560ADQ24798067-E4BC98E7-B025-427B-9AD8-1F875F91B648Q24804699-6A412F42-77D9-444F-8A88-5FC2F268734AQ26742101-7C1356D2-675C-47B8-9603-532A87B1C0AEQ26781765-66ECA730-D0BC-42CC-A827-599518C12189Q27022391-CB2E25B0-01E9-4125-B76C-9FDBD77491AFQ27649369-7B949D4D-5F51-42DD-B7E0-EEEC9BF744F3Q27649423-C66425BD-09FF-4C79-B16C-E39548B0AF9BQ28076505-C6C89627-6A79-48B8-8092-6E531054A864Q28087726-4B2576A0-C889-4260-AE9E-07FE05B1485EQ31148491-FF40669F-26E5-4250-B599-24782B1B9BE5Q33571853-9C84F3FE-E1A2-4428-8FB3-B184EF9A340FQ33977201-E5478A51-B752-433A-868C-771A80BDE68DQ34112677-F909B471-06A8-44EE-8125-B5CD93FF9E11Q34227816-602F8952-456F-4B59-8574-739AD177A07CQ34359990-8CDC02D6-63D2-4BB6-840F-A15920B53266Q34369116-42D4B0DB-319D-4492-BDDD-1531C3FF250EQ34371115-EE271C1C-4BB4-433B-930B-495B1A4E8AB9Q34546465-64043C93-206F-4C9B-8A01-72C900E26D61Q34559789-7270261D-18A6-40A6-985A-B99A9872D0DCQ34604173-9DC0099A-2975-4C3C-BE45-767A4D6267DCQ34661366-515BE65E-8B9C-481B-AC6B-29173C8F18EBQ35030822-E7393D23-E634-4354-B947-C8F8955BF2F0Q35126088-A23A2416-007D-42FF-9F64-606C7B94A201Q35182689-7C9296EB-AA6C-4819-9EE7-4FC9FA205E14Q35594867-2C8653AF-1CDC-4796-AB1E-A5EAEEB0D475Q35633205-2EC09FD7-328C-4C9E-83B5-2C98BD048EB0Q35903029-8D937EF9-B3B0-45C6-93BC-906A837429D2Q35934744-C1C85397-5942-418F-B5E3-49869333D20BQ35975992-6981BF3C-BC19-44A5-BC3C-8E635FB149F6Q36061831-D9A8B328-199C-4E4F-9522-EAD981BEB1B6Q36194224-8D7A08F7-1D64-4396-B215-59158D9CCBC1Q37051229-430286C7-4208-4F36-BFC2-3B3D38231C22Q37257526-94C939C1-F66D-46F4-9770-AB9E5D57CBCFQ37346057-392BBAAA-B7BD-4F6C-8355-0D114E21ED24Q37418054-3924D72F-B808-4420-9D13-F1160BFDB125Q37771934-52F8D4D1-1574-4D7A-ACBD-90B64C36ED69Q37826110-49943F6F-D313-4D86-8DF6-F85E36EF09A3Q38000056-C58FB345-2DA2-4EA8-961B-23B7C03ADADD
P2860
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
description
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique The Lancet
@fr
artículu científicu espublizáu en 2000
@ast
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/04/29)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/04/29)
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@ast
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@en
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@nl
type
label
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@ast
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@en
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@nl
prefLabel
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@ast
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@en
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@nl
P2093
P3181
P1433
P1476
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
@en
P2093
A. W. Lohse
J. Henninger
K. H. Meyer zum Büschenfelde
S. Brunner
S. Kanzler
P304
P3181
P356
10.1016/S0140-6736(00)02166-8
P407
P577
2000-04-29T00:00:00Z